GSK decreasing number of employees while enlarging directors’ salaries

GlaxoSmithKline(GSK), which tightened up the financial status through laying off 176 employees last year, was observed, on the other hand, to increase the amount of compensations to the management(excluding severance pay) by 13.5% compared to the year before.

According to the audit report turned in by GSK to the Financial Supervisory Service, its short-term benefits(salary, profit shares, bonu...